Fundraisings and IPOs

1 2 3 59
Number of results: 1175
Date Company Amount Funding type Investors Therapeutic area Type of Information
2017-03-27 Adaptimmune (UK) $61.8 million IPO Cancer - Oncology Capital increase
2017-03-22 Vect-Horus (France) € 2.5 million fundraising Provençale et Corse, BPMed (France) CNS diseases - Neurological diseases - Neurodegenerative diseases - Cancer - Oncology Fundraising
2017-03-22 Heat Biologics (USA - NC) IPO Cancer - Oncology IPO
2017-03-22 Relief Therapeutics (Switzerland) CHF 500’000 capital increase GEM Global Yield Fund Establishment of a new subsidiary in the EU
2017-03-21 RegenXBio (USA - MD) $75.85 million private placement Rare diseases - Genetic diseases Private placement
2017-03-20 Aurinia Pharmaceuticals (Canada) $173.1 million private placement Autoimmune diseases - Immunological diseases Private placement
2017-03-20 Advicenne (France) €16 million financing round IRDI SORIDEC Gestion (France) Cemag Invest (France) MI Care (Luxembourg) InnoBio Bpifrance (France) IXO Private Equity (France) private individuals. Kidney diseases - Renal diseases - Neurological diseases Fundraising
2017-03-20 Pulmocide (UK) $30.4 million series B financing round SR One (UK) Longwood Fund  SV Life Sciences (USA - MA) F-Prime Capital (USA - MA) Johnson &Johnson Innovation - JJDC (USA-NJ) Touchstone Innovations (UK) Infectious diseases - Respiratory diseases Fundraising
2017-02-27 Exonics Therapeutics (USA - TX) $ 5 million financing round CureDuchenne Ventures (USA - CA) Rare diseases - Genetic diseases - Neuromuscular diseases Financing round
2017-02-20 Centauri Therapeutics (UK) £4.2 million (€ million) financing round Animatrix Capital (UK) private investors Infectious diseases Financing round
2017-02-15 Signum Biosciences (USA - NJ) $ 3 million grant National Institute of Allergy and Infectious Diseases (NIAID) (USA) Dermatological diseases Grant
2017-02-14 Inventiva (France) € 48 million IPO Fibrotic diseases - Hepatic diseases - Liver diseases IPO
2017-02-10 Santhera Pharmaceuticals (Switzerland) CHF 60 million (€ 56.18 million) Rare diseases - Genetic diseases - Hematological diseases Private placement
2017-02-08 Coherus Biosciences (USA - CA) private placement Private placement
2017-02-08 Acticor Biotech (France) €2,9 million financing round Cap Decisif Management (France) Cardiovascular diseases - Cerebrovascular diseases Financing round
2017-02-08 Galena Biopharma (USA - OR) private placement Private placement
2017-02-07 Prexton Therapeutics (Switzerland) € 29 million series B financing round Forbion Capital Partners (The Netherlands) Seroba Life Sciences (Ireland) Merck Ventures (The Netherlands) Ysios Capital (Spain) Sunstone Capital (Denmark) Neurodegenerative diseases - CNS diseases Series B financing round
2017-02-07 Lysogene (France) € 22.6 million IPO Sofinnova Partners (France) BpiFrance (France) Novo A/S (Denmark) Financière Arbevel (France) Alto Invest (France) Rare diseases - Genetic diseases IPO
2017-02-07 OncoSNIPE® consortium (Oncodesign, Expert System, Sword, Acobiom, Hôpitaux Universitaires de Strasbourg, Centre George François Leclerc, Institut Paoli Calmettes) €7.7 million subvention Bpifrance (France) Cancer - Oncology Subvention
2017-01-20 Affimed (Germany) private placement Cancer - Oncology Private placement